Health Technology Wales

What Health Technology Wales does

Health Technology Wales (HTW) is a national health technology assessment body established in 2018, funded by Welsh Government and hosted within Velindre University NHS Trust while operating independently of both. Its core function is to assess non-medicine health and care technologies — including medical devices, diagnostics, procedures, and psychological therapies — and to produce national guidance for NHS Wales and its constituent health boards. HTW's product portfolio comprises a formal Appraisal Process, Evidence Appraisal Reports, Topic Exploration Reports, Rapid Summaries, Adoption Audit Reports, and an Industry User Group / Stakeholder Forum Group mechanism for engagement. It also co-delivers the Wales COVID-19 Evidence Centre with Cardiff University as a Collaborating Partner.

The organisation runs a fee-based Scientific Advice Service (SAS) offering expert consultancy to technology developers and innovators on evidence generation and market access, positioned as complementary commercial revenue alongside its grant-funded national guidance function. HTW participates in international HTA networks including EUnetHTA, INAHTA, and collaborates bilaterally with NICE Scientific Advice and the Scottish Health Technologies Group (SHTG); it won the INAHTA 2025 Best Oral Presentation Award for work on Environmental Impact Assessment in HTA. A Strategic Plan covering 2026-2030 has been published, formalising forward agenda.

HTW serves four segments: NHS Wales and Health Boards (primary, guidance recipients), Technology Developers and Innovators (SAS users), Social Care Providers, and Patients/Public (via the Patient and Public Involvement Standing Group). The primary customer relationship is with NHS Wales as both host and primary guidance consumer; funding is provided by Welsh Government. Distribution of guidance and reports occurs via the healthtechnology.wales website, with awareness driven through quarterly newsletters, guidance alerts, and social media (Twitter/X, LinkedIn, YouTube, Bluesky).

Name

Health Technology Wales

Legal name

Health Technology Wales

Website

https://healthtechnology.wales

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Health Technology Wales is a national body funded by Welsh Government that assesses non-medicine health and care technologies and produces independent national guidance for NHS Wales and its health boards.

Ownership category

akta.pro rank

Product category

Health Technology Assessment

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Health Technology Assessment (HTA) & Reimbursement Policy Bodies (HLAJACAF)

akta.pro secondary industry

Health Systems Performance & Quality Measurement (Public Sector) (HLAJANAK)

Keywords

• Health technology assessment
• Evidence-based guidance
• Medical device appraisal
• Scientific advice service
• National health guidance

Headquarters

HQ city

Cardiff

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Distribution channels1 record

Marketing channels9 records

Core offering

Health Technology Wales is a national body that assesses non-medicine health and care technologies (including medical devices, diagnostics, procedures, and psychological therapies) and produces national guidance on their adoption across NHS Wales. It also delivers a fee-based Scientific Advice Service for technology developers and operates the Wales COVID-19 Evidence Centre, providing rapid evidence reviews for health and social care stakeholders.

Product overview

Health Technology Wales is a national body that assesses non-medicine health and care technologies and produces national guidance on their use in Wales. Rather than a software product company, HTW offers a portfolio of assessment and advisory services including: an Appraisal Process for evaluating health technologies; a Scientific Advice Service (SAS) providing fee-based consultancy to technology developers; the Wales COVID-19 Evidence Centre collaboration for rapid evidence synthesis; Adoption Audit Reports tracking guidance uptake; Topic Exploration Reports for initial evidence reviews; Evidence Appraisal Reports for comprehensive assessments; and Rapid Summaries for urgent evaluations. The organization operates as a public health technology assessment body, not as a technology product vendor.

Differentiator

Problem solved

Functional benefit

Products and services

• Appraisal Process A systematic, national process for assessing non-medicine health technologies (medical devices, diagnostics, procedures, psychological therapies) and producing national guidance on their use in Wales. It is delivered for NHS Wales, Health Boards, technology developers, and social care stakeholders.
• Scientific Advice Service (SAS) A fee-based expert consultancy service that helps health technology developers and innovators generate evidence and demonstrate service value that meets the needs of care commissioners, care providers, patients and service users in Wales. Suitable for medical devices, diagnostics, and procedures.
• Wales COVID-19 Evidence Centre A dedicated centre providing rapid review and synthesis of UK-wide and international research evidence to support decision making by health and social care stakeholders in Wales during the COVID-19 pandemic, with HTW acting as a Collaborating Partner.
• Adoption Audit Reports Reports that summarise how HTW national guidance has been used and any facilitators and barriers to adoption across health and social care in Wales, supporting transparency and accountability in implementation.
• Topic Exploration Reports Initial exploratory reports on topics proposed to HTW for appraisal, providing early-stage evidence reviews to determine which topics should proceed to full appraisal.
• Evidence Appraisal Reports Comprehensive reports assessing the clinical and cost-effectiveness of non-medicine health technologies as part of HTW's national Appraisal Process, leading to published national guidance.
• Rapid Summaries Quick-turnaround evidence assessment summaries produced for urgent health technology questions, providing timely evidence support to NHS Wales and stakeholders.

Quantifiable outcome

• 463+ topics proposed, 56 progressed to appraisal, 33 guidance pieces published
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core and minor.

• NHS WalescoreStrategic or Co-development PartnerNHS Wales is a key partner and primary recipient of HTW guidance. HTW is hosted within NHS Wales but operates independently.
• Welsh GovernmentcoreStrategic or Co-development PartnerHTW is funded by the Welsh Government and collaborates on health technology policy across Wales.
• Velindre University NHS TrustcoreStrategic or Co-development PartnerHTW is hosted within Velindre University NHS Trust. Partnership for operational infrastructure and governance.
• Wales COVID-19 Evidence CentrecoreStrategic or Co-development PartnerHTW is a Collaborating Partner of the Wales COVID-19 Evidence Centre, providing research expertise and input. The centre is funded by Welsh Government and hosted by Cardiff University.
• EUnetHTAminorStrategic or Co-development PartnerCollaborated on pan-European reviews including COVID-19 antibody tests and convalescent plasma therapy assessments.
• NICE Scientific AdviceminorStrategic or Co-development PartnerCollaborated on delivery of META Tool Medtech assessments and rapid advice around digital health technologies for COVID indications.
• Scottish Health Technologies Group (SHTG)minorStrategic or Co-development PartnerCollaborated on shared outputs and close working to maximise evidence contribution and avoid duplication of effort during COVID-19.
• International Network of Agencies for Health Technology Assessment (INAHTA)minorStrategic or Co-development PartnerHTW participates in INAHTA and won the INAHTA 2025 Best Oral Presentation Award for work on Environmental Impact Assessment in HTA.
• Cardiff UniversityminorStrategic or Co-development PartnerCardiff University hosts the Wales COVID-19 Evidence Centre, a key collaborative partner for HTW.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Others

• EUnetHTA: European network of HTA organisations coordinating joint and collaborative assessments across Europe. HTW has actively collaborated with EUnetHTA on COVID-19 antibody and convalescent plasma reviews, making it a closely linked ecosystem partner rather than a competitor.
• INAHTA (International Network of Agencies for Health Technology Assessment): Global network of 50+ HTA agencies. HTW is a member and recently won the INAHTA 2025 Best Oral Presentation Award, positioning INAHTA as a peer network/ecosystem rather than a competing assessment body.

Direct peers

• ZIN (Zorginstituut Nederland) - National Health Care Institute: Dutch national body responsible for HTA and reimbursement decisions on health technologies. A directly comparable national HTA agency producing guidance for a publicly funded health system with a similar mandate to HTW.
• CADTH (Canadian Agency for Drugs and Technologies in Health): Canada's national HTA agency producing health technology assessments and reimbursement recommendations for Canadian health systems. Directly comparable in producing national HTA guidance for a publicly funded health system.
• NICE (National Institute for Health and Care Excellence): The UK's flagship health technology assessment body, producing national guidance on health technologies including the Technology Appraisal Programme. Directly comparable in mandate (national HTA) and outputs (national guidance), but broader in scope as it also covers medicines and clinical guidelines.
• Scottish Health Technologies Group (SHTG): Scotland's national HTA body, producing guidance on non-medicine health technologies for NHSScotland. A near-perfect structural parallel to HTW with the same technology scope and similar NHS-based customer; HTW already collaborates with SHTG.
• AHRQ Effective Health Care Program: US agency-funded program producing comparative effectiveness reviews and technology assessments for the US healthcare system. Comparable in producing evidence-based HTA reports funded through public sources rather than commercial sales.
• NICE Scientific Advice: The fee-based consultancy arm of NICE providing scientific advice to medtech and pharma developers. Directly comparable to HTW's Scientific Advice Service; HTW has already partnered with NICE Scientific Advice on META Tool Medtech assessments.
• HIQA (Health Information and Quality Authority): Ireland's statutory body for health technology assessment and quality assurance, producing HTA reports informing health service decisions. Comparable as a national, publicly mandated HTA producer serving a single health system.

Regional players

• Life Sciences Hub Wales: Wales-based organisation driving health innovation and economic growth in the life sciences sector. Comparable as a Welsh ecosystem player connecting technology developers with NHS Wales, although focused on innovation adoption rather than HTA.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/healthtechwales?lang=en
• YouTubeyoutube.com/channel/UCQ3LI4Ch7fI7r2ZuDj7-YSA
• LinkedInlinkedin.com/company/healthtechnologywales

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Technology Wales